Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Interleukins × Clear all

Phase

Status

Sponsor Class

OTHER 6 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1

Interventions

pembrolizumab 860 Carboplatin 807 Paclitaxel 792 Gemcitabine 662 Cisplatin 640 Docetaxel 603 Bevacizumab 538 Nivolumab 430 Pemetrexed 416 Cyclophosphamide 404 Capecitabine 398 Fluorouracil 341 Dexamethasone 338 Rituximab 336 Oxaliplatin 291 Injections 285 atezolizumab 266 Trastuzumab 262 Cetuximab 243 Leucovorin 235 Prednisone 220 Irinotecan 220 130-nm albumin-bound paclitaxel 218 Doxorubicin 210 Ipilimumab 201 Lenalidomide 197 Fulvestrant 189 fludarabine 181 durvalumab 177 Drug Therapy 172

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01856023 2023-12-05

PROCLIVITY02

Clinigen, Inc.

Phase 4 Terminated

29 enrolled 9 charts

Melanoma, Neoplasm Metastasis, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡